Flat rate shipping — $9 dry goods · $13 chilled gel 🌿

resources

TGA Advertising Rules: What Sea Moss Brands Can and Cannot Say

Australian law draws a hard line between food and therapeutic goods. This article explains what sea moss brands can and cannot legally claim under FSANZ Standard 1.2.7 and the TGA Advertising Code.

General information, not medical advice. Sea moss contains iodine. Ask your GP before use if you have a thyroid condition, take medication, or are pregnant or breastfeeding. Quality & Testing.

## Introduction: Why we hedge, and why it matters If you have spent any time on sea moss social media, you have seen the claims: "cures thyroid disease," "heals your gut," "treats acne from the inside out." At SeaMossVibes, we do not use that language. Some customers find this frustrating. If the product is genuinely beneficial, why the cautious phrasing? The answer is not timidity. It is Australian law. Australia regulates food and therapeutic goods under two entirely separate legislative frameworks. Food Standards Australia New Zealand (FSANZ) governs what food labels and advertisements may say, while the Therapeutic Goods Administration (TGA) regulates medicines, supplements, and devices listed on the Australian Register of Therapeutic Goods (ARTG). The boundary between these two regimes is not a suggestion. It is a legal line with significant financial and criminal penalties for businesses that cross it (Therapeutic Goods Administration, 2023a). This article decodes that boundary. It explains what FSANZ Standard 1.2.7 permits, what the TGA prohibits, and why our editorial choices are a direct consequence of compliance rather than a lack of confidence in the product. ## The food-medicine boundary: Two separate regulatory worlds The first principle to understand is classification. In Australia, a product is either a food or a therapeutic good. It cannot be both simultaneously. ### How the TGA defines therapeutic goods Under the Therapeutic Goods Act 1989 (Cth), therapeutic goods are broadly defined as products for use in humans in connection with preventing, diagnosing, curing, or alleviating a disease, ailment, defect, or injury. The definition specifically excludes goods that are foods within the meaning of the Australia New Zealand Food Standards Code (Therapeutic Goods Administration, 2023a). However, and this is the critical point for sea moss retailers, the way a product is *presented* to consumers can trigger reclassification. The TGA's Food-Medicine Interface Guidance Tool (FMIGT) assesses whether a product is likely to be taken by someone to be for therapeutic use "because of the way in which it is presented" (Therapeutic Goods Administration, 2014). ### What triggers reclassification ``` Product sold as FOOD Product making THERAPEUTIC CLAIMS (regulated by FSANZ) (regulated by TGA) | | v v "Sea moss gel source of iodine" "Sea moss gel treats hypothyroidism" | | v v Permitted under Standard 1.2.7 May be reclassified as an unlisted (if qualifying criteria are met) therapeutic good under TG Act 1989 ``` > A food product that claims to "cure," "treat," "prevent," or "heal" a disease may be deemed a therapeutic good by the TGA regardless of its ingredients or traditional food status. The trigger is the claim, not the composition. > -- Therapeutic Goods Administration (2014), Food-Medicine Interface Guidance Tool. ## FSANZ Standard 1.2.7: What food products may claim Standard 1.2.7 of the Australia New Zealand Food Standards Code is the primary instrument governing nutrition content claims and health claims on food labels and in food advertising. It became law on 18 January 2013 and establishes three tiers of permitted claims (Food Standards Australia New Zealand, 2024). ### Tier 1: Nutrition content claims These describe the nutrient content of a food without linking it to a health outcome. Examples include "source of iodine" or "contains iron." The food must meet specified compositional criteria for the claimed nutrient. ### Tier 2: General level health claims These link a nutrient or substance in a food to a health effect that does not reference a serious disease. An example: "calcium for healthy bones and teeth." General level health claims may be based on either: - **Pre-approved food-health relationships** -- more than 200 are listed in the Food Standards Code - **Self-substantiated relationships** -- the business conducts a systematic review following Schedule 6 methodology and notifies FSANZ before use Crucially, all health claims are prohibited on foods that fail the Nutrient Profiling Scoring Criterion (NPSC), which penalises products high in saturated fat, sugar, or sodium (Food Standards Australia New Zealand, 2024). ### Tier 3: High level health claims These reference a serious disease or a biomarker of a serious disease. For example: "Diets high in calcium may reduce the risk of osteoporosis in people 65 years and over." High level health claims must be based exclusively on pre-approved food-disease relationships listed in Schedule 4 of the Food Standards Code. There are currently only 13 such relationships (Food Standards Australia New Zealand, 2024; Science Learning Hub, 2016). ### Where sea moss stands Sea moss does not currently appear in any of the 13 pre-approved high level health claim relationships in Schedule 4. This means no sea moss food product in Australia may legally make a high level health claim linking it to a serious disease such as thyroid dysfunction, cardiovascular disease, or cancer. | Claim tier | What it says | Permitted for sea moss? | | --- | --- | --- | | Nutrition content claim | "Source of iodine" | Yes, if the product meets compositional criteria for iodine content | | General level health claim | "Iodine contributes to normal thyroid function" | Potentially, if the product meets NPSC and qualifying criteria, and uses pre-approved or validly self-substantiated wording | | High level health claim | "May reduce the risk of thyroid disease" | No. Sea moss is not listed in Schedule 4 | | Therapeutic claim | "Treats hypothyroidism" | Prohibited. Would trigger TGA reclassification | ## The TGA Advertising Code: What you cannot say about therapeutic goods Even if a sea moss product were listed on the ARTG as an AUST L or AUST R medicine, its advertising would still be constrained by the Therapeutic Goods Advertising Code 2021, which took full effect on 1 July 2022 (Therapeutic Goods Administration, 2022). ### Key prohibitions The Code requires that advertisements for therapeutic goods: - [ ] Must not be misleading or deceptive, or likely to mislead or deceive - [ ] Must not use paid or incentivised testimonials (a reversal of the 2018 Code, which permitted them with disclosure) - [ ] Must not reference serious diseases requiring professional diagnosis without TGA pre-approval - [ ] Must not cause "undue distress, fear or alarm" - [ ] Must include mandatory statements such as "always follow the directions for use" (Mondaq, 2021; Dundas Lawyers, 2022) ### Why this matters for sea moss Most sea moss products sold in Australia are sold as food. They are not listed on the ARTG. They do not carry an AUST L or AUST R number. This means they cannot borrow the permitted low-level indications available to listed medicines (such as "supports immune system health" or "helps maintain bone density"), because those indications are tied to ARTG listing status (Zenutri, 2026). > An AUST L listing confirms that the product contains what its label states and was manufactured to pharmaceutical standards, but it does not include pre-market efficacy review. AUST R registered medicines require comprehensive pre-market assessment of safety, quality, and efficacy. > -- Zenutri (2026), TGA-Listed Supplements Australia. ## Penalties: The cost of crossing the line The consequences of making therapeutic claims about an unlisted product, or breaching the Advertising Code, are substantial. ### Under the Therapeutic Goods Act 1989 | Offence | Individual penalty | Corporate penalty | | --- | --- | --- | | Supplying or advertising an unlisted therapeutic good (where harm results or is likely) | Up to $1.32 million and/or 5 years imprisonment | Up to $6.6 million | | Non-compliance with Advertising Code (s 42DM / s 42DMA) | Infringement notices from $2,664 to $7,992 per offence; court-imposed penalties up to $1.32 million | Up to $6.6 million | (MinterEllison, 2025; Therapeutic Goods Administration, 2023b) ### Under Australian Consumer Law The Australian Competition and Consumer Commission (ACCC) can pursue separate action under the Competition and Consumer Act 2010 (Cth) for misleading or deceptive conduct. A business that claims its sea moss "cures" a condition may face ACCC enforcement alongside TGA action. Penalties under the ACL are significant: the Federal Court ordered Heinz to pay $2.25 million for misleading health representations on a children's snack product (ACCC, 2024). The ACCC assesses the "dominant impression" created by a statement. Even a literally true claim can be misleading if the overall impression is deceptive. And intent does not matter; a business can breach the ACL without knowing its claim was misleading (ACCC, 2024). ## Self-assessment: Is your sea moss marketing compliant? Use this checklist to evaluate whether your product claims stay within the legal boundary. - [ ] **Classification check:** Is your product sold as a food (not listed on the ARTG)? If yes, you cannot make therapeutic claims. - [ ] **Nutrition content claims:** Do you meet the compositional criteria for any nutrient you reference (e.g., iodine, iron)? - [ ] **General level health claims:** Are your food-health relationships either pre-approved by FSANZ or validly self-substantiated and notified? - [ ] **High level health claims:** Are you referencing a serious disease? If so, is the specific food-disease relationship listed in Schedule 4? (For sea moss, the answer is currently no.) - [ ] **Therapeutic language audit:** Have you removed all instances of "cures," "treats," "prevents," "heals," "fights," or "repairs" from your product pages, labels, and social media? - [ ] **Testimonial review:** Are any customer testimonials implying guaranteed health outcomes or referencing serious diseases? - [ ] **NPSC compliance:** Does your product pass the Nutrient Profiling Scoring Criterion before making any health claim? - [ ] **Mandatory disclosures:** If you reference iodine, have you noted the tolerable upper intake level of 1,100 mcg/day and recommended practitioner consultation for thyroid conditions? ## Why SeaMossVibes uses the language it does Our editorial standard follows directly from this regulatory framework. When we write that sea moss "contains iodine, which contributes to normal thyroid hormone production," we are using language modelled on the pre-approved general level health claim structure under Standard 1.2.7. When we add "consult your practitioner before use if you have a thyroid condition," we are acknowledging the food-medicine boundary and acting within the spirit of both FSANZ and TGA guidance. We also distinguish evidence tiers in our content. When a study is preclinical (cell culture or animal model), we say so. When human clinical trial data is absent, we note that explicitly. This is not hedging for the sake of hedging. It is the only honest way to communicate the current state of the science. For a deeper look at where the evidence stands and where it does not, see [Beyond the Hype: The Science and Pseudoscience of Sea Moss](/blogs/learn/benefits/sea-moss-science-pseudoscience). ### Our sourcing and testing disclosures Because this article discusses the regulatory environment, readers should also understand our supply chain context: - **Species verification:** We source wild-harvested *Chondrus crispus* from Saint Lucia and verify species identity per lot. We do not sell *Gracilaria* or *Eucheuma* species under the "sea moss" label without disclosure. - **Heavy metal testing:** Each lot undergoes ICP-MS elemental analysis and HPLC-ICP-MS arsenic speciation to distinguish toxic inorganic arsenic from benign organic arsenosugars. Certificates of Analysis (COAs) are available on request. - **Iodine quantification:** Iodine is quantified in mcg/g per lot. The tolerable upper intake level for iodine in healthy adults is 1,100 mcg/day; a single serving of dried sea moss can approach or exceed this limit. If you have a thyroid condition, are pregnant, take anticoagulants, or have cardiovascular disease, consult your practitioner before use. - **Allergen note:** Sea moss is a marine product. If you have known allergies to seaweed or marine organisms, exercise caution and consult your healthcare provider. ## Conclusion Australian food and therapeutic goods law is not ambiguous. The line between a permitted health claim and an illegal therapeutic claim is drawn clearly by FSANZ Standard 1.2.7 and enforced by the TGA and ACCC with penalties that can reach seven figures. For consumers, this regulatory framework is a protection: it means that when a brand uses measured, evidence-graded language, that brand is respecting both the law and the limits of the current science. Brands that promise miracle outcomes for a food product are either uninformed about or indifferent to their legal obligations. For retailers, compliance is not optional. The TGA's Food-Medicine Interface Guidance Tool, the FSANZ health claims schedules, and the ACCC's misleading conduct provisions together create a regulatory environment where every claim on a label, website, or Instagram post must be defensible. At SeaMossVibes, our conservative language is a feature, not a limitation. It reflects our commitment to clinical honesty, regulatory compliance, and the trust of an Australian consumer base that deserves better than marketing slogans dressed up as medical advice. **This article is for informational purposes only and does not constitute legal advice. Businesses should seek independent legal counsel for compliance with TGA, FSANZ, and ACCC requirements. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare practitioner before making changes to your diet, particularly if you have thyroid conditions, cardiovascular disease, are pregnant or breastfeeding, or take anticoagulant medication.** ## Next step Want to understand how we grade evidence and report iodine safety for the sea moss we actually sell? [Take the Mineral Blueprint assessment](/vitality/assessment) to see whether gel or capsules match your primary goal, built around verified nutrients and Australian regulatory standards. ## References - Australian Competition and Consumer Commission. (2024). *False or misleading claims*. ACCC. https://www.accc.gov.au/consumers/advertising-and-promotions/false-or-misleading-claims - Dundas Lawyers. (2022). *A guide to the Therapeutic Goods Advertising Code 2021*. Dundas Lawyers. https://www.dundaslawyers.com.au/a-guide-to-the-therapeutic-goods-advertising-code-2021/ - Food Standards Australia New Zealand. (2024). *Nutrition, health and related claims*. FSANZ. https://www.foodstandards.gov.au/business/labelling/nutrition-health-and-related-claims - MinterEllison. (2025). *Regulators crack down on therapeutic goods advertising: key TGA, ACCC and Ahpra actions, penalties and compliance tips for businesses*. MinterEllison Insights. https://www.minterellison.com/articles/unlawful-pharma-and-health-service-advertising-in-regulators-sights - Mondaq. (2021). *Influencing for profit: The new Therapeutic Goods Advertising Code 2021 -- what you need to know*. Mondaq. https://www.mondaq.com/australia/food-and-drugs-law/1190964/influencing-for-profit-the-new-therapeutic-goods-advertising-code-2021-what-you-need-to-know - Science Learning Hub. (2016). *Health claims and food products*. Science Learning Hub. https://www.sciencelearn.org.nz/resources/2285-health-claims-and-food-products - Therapeutic Goods Administration. (2014). *Food-Medicine Interface Guidance Tool (FMIGT) -- plain version*. TGA. https://www.tga.gov.au/resources/decision-trees/food-medicine-interface-guidance-tool-fmigt/food-medicine-interface-guidance-tool-fmigt-plain-version - Therapeutic Goods Administration. (2022). *New Therapeutic Goods Advertising Code 1 January 2022*. TGA. https://www.tga.gov.au/news/media-releases/new-therapeutic-goods-advertising-code-1-january-2022 - Therapeutic Goods Administration. (2023a). *What are therapeutic goods?* TGA. https://www.tga.gov.au/products/regulations-all-products/regulation-essentials/what-are-therapeutic-goods - Therapeutic Goods Administration. (2023b). *Information about infringement notices*. TGA. https://www.tga.gov.au/how-we-regulate/compliance-and-enforcement-hub/compliance-actions-and-outcomes/information-about-infringement-notices - Zenutri. (2026). *TGA-listed supplements Australia: What AUST L, AUST L(A), and AUST R actually guarantee -- and what they don't*. Zenutri. https://zenutri.com.au/blogs/news/tga-listed-supplements-australia-a-complete-guide-to-safety-quality

Ready to start?

Turn what you learned into a daily ritual

Explore formats and product details, then check the physical label before use.

Explore products →

Listed ingredients · Storage guidance

Read next

  • Listed product details
  • Available report scope
  • Secure checkout
  • Shipping policy available